We are live on
!
Find out more
RA
Resolute Advisors Portfolio holdings
AUM
$242M
1-Year Est. Return
52.95%
This Fund
S&P 500
This Quarter
Est. Return
-54.59%
1 Year Est. Return
+52.95%
3 Year Est. Return
+38.33%
5 Year Est. Return
-44.39%
10 Year Est. Return
–
AUM
$963M
AUM Growth
-$1.4B
(-59%)
Cap. Flow
-$10.4M
Cap. Flow
% of AUM
-1.08%
Top 10 Holdings %
Top 10 Hldgs %
96.39%
Holding
139
New
7
Increased
24
Reduced
15
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aurora
AUR
|
+$1.87M |
| 2 |
EMBK
Embark Technology, Inc. Common Stock
EMBK
|
+$292K |
| 3 |
Weave Communications
WEAV
|
+$192K |
| 4 |
NXDR
Nextdoor Holdings
NXDR
|
+$157K |
| 5 |
AbCellera Biologics
ABCL
|
+$119K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.72M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.47M |
| 3 |
Roblox
RBLX
|
+$2.04M |
| 4 |
Unity
U
|
+$1.19M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$888K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 89.54% |
| 2 | Communication Services | 1.22% |
| 3 | Consumer Discretionary | 0.29% |
| 4 | Healthcare | 0.11% |
| 5 | Consumer Staples | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Roku
ROKU
$21.4B
| – | – |
-158
| Closed | -$20K |
|
127
Teladoc Health
TDOC
$1.7B
| – | – |
-273
| Closed | -$20K |
|
|
128
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| – | – |
-9,884
| Closed | -$888K |
|
|
ASTR
129
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| – | – |
-1,178
| Closed | -$68K |
|
|
NVTA
130
DELISTED
Invitae Corporation
NVTA
| – | – |
-1,054
| Closed | -$8K |
|
|
ZNGA
131
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| – | – |
-89,497
| Closed | -$827K |
|
Similar funds
TA
SC
DA
FWM
BWG
ITFISA
TPF
DO
Resolute Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Resolute Advisors held 139 positions worth $963M, down 59% from $2.36B the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Resolute Advisors's Q2 2022 filing shows 7 new, 24 increased, 15 reduced and 8 closed positions. Its largest new stake was Aurora: 508,680 shares worth $972K. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $3.72M.
By sector, the portfolio is most concentrated in Technology at 90% of assets, down from 94% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Resolute Advisors's largest Q2 2022 buy was Aurora: 508,680 shares worth $972K.
- Resolute Advisors added most to AbCellera Biologics in Q2 2022, an estimated $119K increase.
- Resolute Advisors's biggest Q2 2022 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $3.72M.
- Resolute Advisors fully exited State Street SPDR S&P Biotech ETF in Q2 2022, selling an estimated $888K.
- Resolute Advisors's ten largest holdings make up 96% of its $963M portfolio in Q2 2022.
- Resolute Advisors opened 7 new positions and closed 8 in Q2 2022.
- Resolute Advisors's portfolio value fell 59% quarter-over-quarter to $963M.
Based on Resolute Advisors's 13F filing for Q2 2022, filed 8 Aug 2022.